Chemoinformaics analysis of Desmethylrocaglamide
| Molecular Weight | 491.54 | nRot | 6 |
| Heavy Atom Molecular Weight | 462.308 | nRig | 27 |
| Exact Molecular Weight | 491.194 | nRing | 5 |
| Solubility: LogS | -4.412 | nHRing | 1 |
| Solubility: LogP | 2.993 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 3 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 18 |
| nHA | 7 | APOL | 72.811 |
| nHD | 3 | BPOL | 37.475 |
| QED | 0.487 |
| Synth | 3.94 |
| Natural Product Likeliness | 1.304 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.886 |
| Pgp-sub | 0.025 |
| HIA | 0.011 |
| CACO-2 | -5.399 |
| MDCK | 0.0000323 |
| BBB | 0.38 |
| PPB | 0.902243 |
| VDSS | 1.303 |
| FU | 0.0429452 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.577 |
| CYP2c19-inh | 0.744 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.635 |
| CYP2c9-sub | 0.409 |
| CYP2d6-inh | 0.39 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.954 |
| CYP3a4-sub | 0.806 |
| CL | 8.712 |
| T12 | 0.194 |
| hERG | 0.32 |
| Ames | 0.526 |
| ROA | 0.686 |
| SkinSen | 0.04 |
| Carcinogencity | 0.106 |
| EI | 0.01 |
| Respiratory | 0.794 |
| NR-Aromatase | 0.936 |
| Antiviral | Yes |
| Prediction | 0.923582 |